Axiomatic AI Raises $18M to Build the Intelligence Infrastructure for Verified Science & Engineering

Leveraging expertise from leading research institutions, the company is developing the AI platform technical organizations will rely on to design, verify, and deploy complex hardware systems at scale.
TMCnet

Data Published in Neurology and Therapy Demonstrate Significant Reductions in Relapse and MRI Activity with BRIUMVI® in People with Highly Active Relapsing Multiple Sclerosis

In participants with highly active disease, the unadjusted annualized relapse rate (ARR) at Week 96 was 0.145 for BRIUMVI versus 0.496 for teriflunomide, representing a 70.8% relative reduction ...

Dyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 (DM1)

Dyne has aligned with the U.S. Food and Drug Administration (FDA) on the HARMONIA Phase 3 trial design and protocol. HARMONIA is intended to serve as a confirmatory trial to support conversion of ...

EY Consumer Beverage Survey: New consumer research finds health-led choices, generational changes and digital discovery are redefining beverage expectations

The EY organization today released findings from its Consumer Beverage Survey, uncovering three major forces – health, digital engagement and generation shifts – that are reshaping beverage choice and ...
The Manila Times

TMates GLP-1 Weight Loss Program Claims Evaluated: 2026 Consumer Research Report on Compounded Semaglutide, Tirzepatide, Telehealth Weight-Loss Access, P…

A 2026 informational consumer research report examining the TMates telehealth weight-loss platform, compounded GLP-1 ...

Dyne commences Phase III HARMONIA trial for DM1 therapy

Dyne Therapeutics has initiated the Phase III HARMONIA trial to evaluate the efficacy, safety, and tolerability of zeleciment basivarsen (z-basivarsen, also called DYNE-101) in individuals diagnosed ...
The American Journal of Managed Care

Cost-Effectiveness of Implementing a Home Blood Pressure Telemonitoring Program

A home blood pressure telemonitoring (HBPT) program effectively reduced BP in real-world clinical settings, but its enrollment expenses increased overall costs. The HBPT program reduced BP clinic ...
The New Yorker

Love in the Time of A.I. Companions

In 2022, Brookins began building an A.I. companion modelled on Geralt of Rivia, a character from a series of fantasy novels ...
The Business & Financial Times

Securing blue economy: why marine protected areas are strategic national assets

By Emmanuel AMEYAW, Project Manager at the Africa Centre for Nature-Based Climate Action (AC4NCA)  Ghana is a nation defined by its coastline, a 550-kilometer stretch of sandy beaches, estuaries, ...
Steel Horse Rides on MSN

Man says his truck requires four different touchscreen menus just to turn on the defroster leaving him frustrated in freezing weather

A truck owner’s viral complaint about needing to navigate through multiple touchscreen menus just to […] ...

Dianthus Therapeutics Announces Early GO Decision Following Interim Responder Analysis in Phase 3 CAPTIVATE Trial of Claseprubart in Chronic Inflammatory Demyelinating ...

Early GO decision reached ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants ...
Seeking Alpha

Roche Holding AG (RHHBY) Discusses Phase III Study Results and Updates on Immunology Kidney Pipeline Transcript

My name is Leonard and I'm the technical operator for today's call. [Operator Instructions] One last remark, if you would like to follow the presented slides on your ...